Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03633006 · ClinicalTrials.gov registry record
Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer
A clinical trial of Lung Cancer (Diagnosis), sponsored by Exact Sciences Corporation.
- Completed
- Registry status
- 3,298
- Enrollment target
- 20
- Study locations
NCT03633006: Completed study of Lung Cancer (Diagnosis), sponsored by Exact Sciences Corporation.
NCT03633006 is a study of Lung Cancer (Diagnosis) that has completed, run by Exact Sciences Corporation. The registered enrollment target is 3,298 participants, below the 4,032-participant average among 6 other Lung Cancer (Diagnosis) trials with a reported enrollment target (18% lower). The trial reports 20 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03633006, a study of Lung Cancer (Diagnosis), has completed, sponsored by Exact Sciences Corporation.
- COMPLETED
- Registry status
- 3,298 participants
- Enrollment target
- 20
- Study locations
Study Summary
The primary objective of this study is to obtain de-identified, clinically characterized, whole blood specimens for use in assessing new biomarkers for the detection of neoplasms of the lung. Subjects will be men and women, 35 years of age and older, with a CT confirmed nodule measuring 6-30 mm.
Primary Outcome
Screening subjects to find the appropriate methylation sites for the detection of lung cancer
Conditions Studied
Interventions
- OTHER Blood Sample Collection
Study Locations (20)
Florida
- American Research Institute, Inc - Cutler Bay
- International Research Partners, LLC - Doral
- Jupiter Medical Center - Jupiter
- Pulmonary Disease Specialists - Kissimmee
- Medical Research of Central Florida, LLC - Leesburg
- Future Clinical Research - Miami
- University of Miami Miller School of Medicine - Miami
- Orcinova AMS Research - Miami
- Sunrise Research Institute, Inc - Miami
- American Research Medical Group - Miami
- Health and Life Research Institute, LLC - Miami
- Care Research Center - Miami
- Clinical Trials of Florida, LLC - Miami
- AMPM research Clinic - Miami Gardens
California
- Newport NativeMD - Newport Beach
- Palmtree Clinical Research, Inc - Palm Springs
- Palo Alto Veterans Health Care - Palo Alto
- Premier Medical Group - Upland
Alabama
- Achieve Clinical Research - Birmingham
Arizona
- Phoenix Medical Group - Peoria
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,298 participants |
| Start Date | 2016-04-11 |
| Est. Completion | 2020-12-31 |
What the finished NCT03633006 record still lists
NCT03633006 is an observational study that tracks outcomes without assigning an intervention. Its 3,298 participants enrollment target places it among the larger protocols in the corpus, below the 4,032-participant average among 6 other Lung Cancer (Diagnosis) trials with a reported enrollment target (18% lower).
The record links to 1 condition, with Lung Cancer (Diagnosis) appearing as the primary indexed condition, and to 1 intervention - of which Blood Sample Collection is the first listed.
NCT03633006 names 20 study sites across 4 states, led by Florida, California, Alabama.
Frequently Asked Questions
What is clinical trial NCT03633006 about?
NCT03633006 is a clinical study titled "Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer". The primary objective of this study is to obtain de-identified, clinically characterized, whole blood specimens for use in assessing new biomarkers for the detection of neoplasms of the lung. Subjects will be men and women, 35 years of age and older, with a CT confirmed nodule measuring 6-30 mm.
What is the current status of trial NCT03633006?
This trial is currently completed. The enrollment target is 3,298 participants. The study started on 2016-04-11. Estimated completion is 2020-12-31.
What conditions does trial NCT03633006 study?
This clinical trial studies the following conditions: Lung Cancer (Diagnosis).
What interventions are being tested in trial NCT03633006?
The interventions under investigation include: Blood Sample Collection (OTHER).
Who is sponsoring clinical trial NCT03633006?
This trial is sponsored by Exact Sciences Corporation, which has 30 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03633006 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer (Diagnosis)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.
RECRUITING · NA
-
SBU-RESET: RElaxation, Stress Reduction and Epigenetics Trial in Cancer Survivors
RECRUITING · NA
-
Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots
RECRUITING
-
Telehealth Collaborative Care Model (CoCM) in Lung Cancer
RECRUITING · NA
-
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
RECRUITING
-
Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans Affairs
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07214610 · 3,300 participants · NA
Integrating Biological, Clinical, and Behavioral Factors to Improve Breast Cancer Outcomes - Carolina Breast Cancer Study
- NCT06815536 · 3,291 participants
Master Protocol for Evaluating Multiple Infection Diagnostics for Ciprofloxacin-Resistant Neisseria Gonorrhoeae
- NCT03674307 · 3,306 participants · NA
Screening for Asymptomatic Coronary Artery Disease in Kidney Transplant Candidates
- NCT06543446 · 3,290 participants · NA
Comparative Effectiveness of Prophylactic ICD Versus Non-ICD Therapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI